Human serum albumin therapy confers neurobehavioral and histopathologic neuroprotection in adult stroke models. We investigated whether albumin might also be neuroprotective in ischemic brain injury ...

Given the size of the stroke depicted in Figure 1 (greater than one third of the hemisphere), thrombolytic therapy would be contraindicated for this patient. Indications of a hemorrhagic stroke ...

A 62 year-old man had an upper GI bleed complicated by severe hypotension. Several days after successful surgical repair of a bleeding gastric ulcer, he was noted to have significant weakness of the ...

Women who experience complications during pregnancy, such as preeclampsia, preterm birth, gestational diabetes, miscarriage, or stillbirth, have an increased risk of ischemic stroke before the age of ...

Thrombectomy is currently recommended for eligible patients with stroke who are treated within 6 hours after the onset of symptoms. We conducted a multicenter, randomized, open-label trial, with ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced its participation in the American Society for Experimental ...

A 51-year-old man presents to emergency after suddenly experiencing weakness on the right side of his body. At the same time, he notes, he began to slur his speech. He has had no health issues ...

The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than ...